About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 6641 record(s)
Req # A-2020-001650
Adverse Reaction Reports (AERs) for FUROSEMIDE. Report numbers: 915058, 000916242, 000916876, 000919335, E2B_03174989, E2B_03210414, E2B_03234268, 000917022.Organization: Health Canada
May 2021
Req # A-2020-001652
Adverse Reaction Reports (AERs) for GLYCERYL TRINITRATE. Report numbers: E2B_03193921, E2B_03172074, E2B_03172067.Organization: Health Canada
May 2021
Req # A-2020-001675
Adverse Drug Reaction (ADR) for LEFLUNOMIDE. Report number: E2B_01198405.Organization: Health Canada
May 2021
Req # A-2020-001676
Adverse Drug Reaction (ADR) for PETHIDINE HYDROCHLORIDE. Report number: E2B_01198405.Organization: Health Canada
May 2021
Req # A-2020-001678
Adverse Drug Reaction (ADR) for HYDROXYCHLOROQUINE SULFATE. Report number: E2B_01198405.Organization: Health Canada
May 2021
Req # A-2020-001715
Adverse Reaction Reports (AERs). Report numbers: 000909929, E2B_03063210, E2B_03062611, E2B_03048826, E2B_03114562, E2B_03121523, E2B_03121652, E2B_03143606, E2B_03177135, E2B_03196748, E2B_03204305, E2B_03204619, E2B_03197922, E2B_02283420,…Organization: Health Canada
May 2021
Req # A-2020-001722
Adverse Reaction Reports (AERs). Report numbers: E2B_03033050, E2B_03316269, E2B_03320853, E2B_03380736.Organization: Health Canada
May 2021
Req # A-2020-001744
Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_02944156.Organization: Health Canada
May 2021
Req # A-2020-001761
Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03470442.Organization: Health Canada
May 2021
Req # A-2020-001765
Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03481143.Organization: Health Canada
May 2021